Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : CNBC -- critique. -- Ignore unavailable to you. Want to Upgrade?

To: lorrie coey who wrote (6089)	6/23/2000 2:35:00 PM
From: Yogizuna	Respond to of 17683

The charts on CYPH are not too bad and can be considered constructive. There is no chart on CRL yet as it's brandy new..... Will see if I can get back with more soon.

To: lorrie coey who wrote (6089)	6/23/2000 2:58:00 PM
From: Yogizuna	Read Replies (1) \| Respond to of 17683

*** OFF TOPIC * CYPH is making a collection of inhibitors of human genes called the "Oasis System", so they can develop an inhibitor of every human gene so they can be turned "on or off" in the future to help out human health. (hopefully) CRL is a new issue today, but it has been in business for about 50 years, and they supply "genetically defined rats and mice, so if you want a "special mouse" or rat for biomedical reasearch, you know who to call! :^)** Yogi